ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag drug development culture policy academia

Dealing with Unethical or Illegal Conduct in Higher Education
Anna Azvolinsky | Nov 1, 2017 | 8 min read
Investigations into cases of wrongdoing by professors are increasingly in the public eye. But are colleges and universities doing enough to deal with the problem?
Opinion: Bias Is Unavoidable
Lisa Cosgrove | Aug 7, 2012 | 4 min read
Simply disclosing conflicts of interest is not enough.
Life Sciences Salary Survey 2011
Jef Akst and Edyta Zielinska | Dec 1, 2011 | 10+ min read
US salaries are starting to recover after last year’s survey recorded the first-ever drop.
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
When Big Pharma Courts Academia
Joseph Paone | Jan 20, 2002 | 6 min read
Norman Greenberg tests AstraZeneca compounds on mice he genetically engineered to develop prostate cancer. He supplies the animals and the system for verifying the effectiveness of chemotherapy treatments while the company provides the compounds and testing costs, and gives Greenberg ample opportunity to prove just how well his system works. Together, the scientist from Baylor College of Medicine in Houston and his corporate partner warily straddle the barrier between academia and industry, and
Industry vs Academia
The Scientist Staff | Apr 15, 2001 | 10+ min read
To conduct this survey, The Scientist invited 1800 readers via E-mail to respond to a web-based survey form. There were a total of 220 responses from March 2 to 12, 2001, a response rate of 12.2%. Have you held research positions in both academia and industry? (Positions may include graduate research, industrial internships, or any other research positions - paid or unpaid - in both work environments).   Percent Count Answers 72.6% 159/219 Yes 27.4% 60/219 No
Week in Review: June 16–20
Tracy Vence | Jun 20, 2014 | 2 min read
Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors
National AIDS Task Force Expected To Accelerate Drug Development
Franklin Hoke | Feb 6, 1994 | 8 min read
Bench scientists will play a major role in an ambitious effort to streamline the campaign against HIV The soon-to-be-appointed National Task Force on AIDS Drug Development may have a strong, positive impact on the research and development of antiviral therapies to counter HIV infection, say industry and academic scientists, government officials organizing the task force, and members of the AIDS-affected community. Key to the task
academic biomedical research pharmaceutical conflict of interest
Opinion: The “Money Culture” in Academic Biomedical Research
David Rubenson | Mar 29, 2019 | 4 min read
A drive for revenue is damaging basic science.
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.

Run a Search

ADVERTISEMENT